Abstract
Coronavirus disease 2019 (COVID-19) is a novel infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This disease represents one of the most significant pandemics in human history [1]. Vaccine has recently been developed [2–4] and is being administered in some countries, but its widespread use is not yet sufficient. The distribution strategy should consider estimated effects of the vaccine. Herein, we assess the estimated effect of the COVID-19 vaccine in patients with epilepsy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
